Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
7.49
-0.01 (-0.13%)
At close: Dec 5, 2025, 4:00 PM EST
7.30
-0.19 (-2.54%)
After-hours: Dec 5, 2025, 8:00 PM EST

Regentis Biomaterials Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.190.230.351.242.741.38
Cash & Short-Term Investments
0.190.230.351.242.741.38
Cash Growth
7.39%-33.62%-72.18%-54.81%98.98%-
Other Receivables
-0.070.010.030.050.01
Receivables
-0.070.010.030.050.01
Prepaid Expenses
-0.180.010.450.33-
Total Current Assets
0.480.480.361.723.121.39
Total Assets
0.480.480.361.723.121.39
Accounts Payable
0.260.250.350.210.310.33
Accrued Expenses
1.281.130.520.420.2-
Short-Term Debt
1.050.570.21---
Current Portion of Long-Term Debt
7.114.37-6.47--
Current Unearned Revenue
--2.051.982.211.21
Other Current Liabilities
-0.160000
Total Current Liabilities
9.716.493.149.082.721.54
Long-Term Debt
--7.41-6.080.47
Other Long-Term Liabilities
--0.620.690.790.7
Total Liabilities
9.716.4911.179.779.582.71
Additional Paid-In Capital
1.041.041.040.750.750.75
Retained Earnings
-45.37-42.15-46.95-42.82-41.23-36.09
Total Common Equity
-44.33-41.1-45.91-42.06-40.48-35.34
Shareholders' Equity
-9.23-6.01-10.81-8.05-6.47-1.33
Total Liabilities & Equity
0.480.480.361.723.121.39
Total Debt
8.164.957.626.476.080.47
Net Cash (Debt)
-7.98-4.72-7.27-5.23-3.330.91
Net Cash Per Share
-49.17-29.08-41.90-32.26-20.545.59
Filing Date Shares Outstanding
3.930.163.930.160.160.16
Total Common Shares Outstanding
0.160.160.160.160.160.16
Working Capital
-9.23-6.01-2.78-7.360.39-0.16
Book Value Per Share
-273.32-253.42-283.02-259.32-249.57-217.87
Tangible Book Value
-44.33-41.1-45.91-42.06-40.48-35.34
Tangible Book Value Per Share
-273.32-253.42-283.02-259.32-249.57-217.87
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q